Maze Therapeutics Announces $190 Million Financing To Support The Advancement Of Nine Precision Medicine Programs And Compass Platform For Genetically Defined Diseases
Amount Raised
$190 Million
Round Type
Funding Round
San FranciscoBiotechnologyHealth CareScience And EngineeringDescription
Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced a $190 million financing led by Matrix Capital Management with participation from General Catalyst, a16z Bio+Health, Woodline Partners, Casdin Capital, City Hill Ventures, Foresite Capital, Driehaus Capital Management, Moore Strategic Ventures, Terra Magnum Capital Partners, NS Investments and several others. Maze was launched in 2019 with a financing led by Third Rock Ventures and ARCH Venture Partners, with participation from GV, Foresite Capital, Casdin Capital, Alexandria Venture Investments and other undisclosed investors and has since generated nine programs and two joint-ventures. In conjunction with the financing, Maze also announced that Matrix Capital Management’s Andy Tran has joined the company’s board of directors.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Maze Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Synthego Corp raised $200M (Funding Round) on February 17, 2022.
- Walking Fish Therapeutics raised $73M (Series A) on February 16, 2022.
- Electra Therapeutics raised $84M (Series B) on February 16, 2022.
- Memo Therapeutics AG raised an undisclosed amount (Series B) on February 16, 2022.
- Variantyx raised $42M (Funding Round) on February 14, 2022.
- Arkuda Therapeutics raised $64M (Series B) on February 10, 2022.
Who to call at Maze Therapeutics, and when
A new round usually means Maze Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Maze Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Maze Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Maze Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Maze Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Maze Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.